At-15 * a phase ii study of antineoplastons a10 and as2-1 in patients with brainstem gliomas final report (protocol bt-11)

CONCLUSION: The results suggest that ANP shows efficacy and acceptable tolerability profile in patients with BSG, RPDIPG, and NDIPG.

Source: Neuro-Oncology - November 3, 2014 Category: Cancer & Oncology Authors: Burzynski, S., Janicki, T., Marszalek, A., Burzynski, G. Tags: ADULT CLINICAL TRIALS Source Type: research